United Therapeutics
UTHR
#1026
Rank
โ‚ฌ19.00 B
Marketcap
420,27ย โ‚ฌ
Share price
1.08%
Change (1 day)
20.34%
Change (1 year)

Revenue for United Therapeutics (UTHR)

Revenue in 2025 (TTM): โ‚ฌ2.80 Billion

According to United Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚ฌ2.68 Billion. In 2024 the company made a revenue of โ‚ฌ2.76 Billion an increase over the revenue in the year 2023 that were of โ‚ฌ2.10 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for United Therapeutics from 1999 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ2.80 B1.27%
2024 โ‚ฌ2.76 B31.33%
2023 โ‚ฌ2.10 B16.64%
2022 โ‚ฌ1.80 B21.29%
2021 โ‚ฌ1.48 B23.41%
2020 โ‚ฌ1.20 B-6.75%
2019 โ‚ฌ1.29 B-9.11%
2018 โ‚ฌ1.42 B-1.04%
2017 โ‚ฌ1.43 B-5.4%
2016 โ‚ฌ1.51 B13.38%
2015 โ‚ฌ1.34 B26.53%
2014 โ‚ฌ1.05 B30.99%
2013 โ‚ฌ0.80 B16.79%
2012 โ‚ฌ0.69 B21.02%
2011 โ‚ฌ0.57 B27.15%
2010 โ‚ฌ0.45 B74.35%
2009 โ‚ฌ0.25 B28.2%
2008 โ‚ฌ0.20 B39.38%
2007 โ‚ฌ0.14 B19.42%
2006 โ‚ฌ0.12 B23.64%
2005 โ‚ฌ97.85 M80.37%
2004 โ‚ฌ54.24 M28.05%
2003 โ‚ฌ42.36 M47.04%
2002 โ‚ฌ28.81 M343.96%
2001 โ‚ฌ6.49 M198.35%
2000 โ‚ฌ2.17 M337.79%
1999 โ‚ฌ0.49 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Eli Lilly
LLY
โ‚ฌ51.03 B 1,799.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ24.98 B 829.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ14.40 B 436.25%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Pfizer
PFE
โ‚ฌ53.92 B 1,906.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
โ‚ฌ9.46 B 252.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
โ‚ฌ74.9 M-97.21%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ36.37 B 1,253.82%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cardinal Health
CAH
โ‚ฌ201.24 B 7,389.77%๐Ÿ‡บ๐Ÿ‡ธ USA